Filing Flows › Envoy Medical (COCH) › R&D spending
Envoy Medical (COCH) R&D spending by quarter
Envoy Medical's R&D spending was $3.1M in Q3 2026 (third quarter 2026), -2% from Q2 2026. Over the last 7 quarters it ranged from $2.5M (Q2 2025) to $4.6M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.1M | -2% | +14% |
| Q2 2026 | $3.1M | -14% | +26% |
| Q1 2026 | $3.6M | -20% | +33% |
| Q4 2025 | $4.6M | +69% | — |
| Q3 2025 | $2.7M | +9% | — |
| Q2 2025 | $2.5M | -10% | — |
| Q1 2025 | $2.7M | — | — |
Q3 2026 at a glance
Envoy Medical, Q3 2026: revenue $66K (+57% year over year), net loss $3.9M, operating cash flow −$5.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Envoy Medical's R&D spending?
Envoy Medical's R&D spending was $3.1M in Q3 2026 (third quarter 2026), -2% from Q2 2026.
How has Envoy Medical's R&D spending changed?
Over the last 7 quarters it ranged from $2.5M (Q2 2025) to $4.6M (Q4 2025).